Case Study: A Groundbreaking Approach Combining Haplo-HSCT and UC-MSCs Offers Hope for Severe Aplastic Anemia
Despite significant strides in immunosuppressive therapy, complete cures remain elusive for many SAA patients. Haplo-HSCT has emerged as a viable alternative, particularly for adult SAA patients. However, its efficacy is marred by a higher incidence of graft failure and graft-versus-host disease (GVHD).